Atlas Trials

Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries.

Clinical trial NCT03423511 · NOT_YET_RECRUITING

Trial details

NCT number
NCT03423511
Sponsor
Micell Technologies
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Coronary Artery Disease
Start date
2021-12-31
Primary completion
2023-06-01
Enrollment
1300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.